Page last updated: 2024-08-23

paclitaxel and Carcinoma, Intraepithelial

paclitaxel has been researched along with Carcinoma, Intraepithelial in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Carlos, L; Colombo, P; De Cobelli, O; Duran-Merino, R; Guazzoni, G; Hurle, R; Lazzeri, M; Nohales, G; Santoro, A; Trapani, ED1
Fan, H; Li, J; Lu, P; Qin, Y; Xu, L1
Keegan, AD; Kingsley, C; Perry, A; Porter, HA; Tran, NL1
Albarracin, C; Downs-Kelly, E; Gould, R; Hatzis, C; Morkowski, J; Peintinger, F; Sinn, B; Symmans, WF1
Fernandez, RO; Iniesta, MD; Lu, KH; Malpica, A; Patrono, MG; Ramirez, PT; Salvo, G1
Bassi, PF; D'Agostino, D; Franchini, S; Palermo, G; Racioppi, M; Renier, D; Rosato, A; Volpe, A1
Bento, S; Dávila, C; Ferreira, A; Pereira, D; Rodrigues, A; Rodrigues, H; Vieira, C1
Li, J; Lin, ZQ; Peng, YP; Wang, LJ; Zhang, BZ1
Cao, D; Hruban, RH; Itami, A; Lee, KM; Maitra, A; Ouellette, MM; Pour, PM1
Wang, HJ; Zheng, WX1
Baile, WF; Beale, EA; Glober, GA; Kudelka, AP; Lenzi, R1
Furukawa, T; Irie, K; Iwanaga, K; Katoh, O; Kuroki, S1

Reviews

4 review(s) available for paclitaxel and Carcinoma, Intraepithelial

ArticleYear
Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
    Gynecologic oncology, 2015, Volume: 139, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Fallopian Tube Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Humans; Incidence; Mutation; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Platinum Compounds; Salpingectomy

2015
Neoadjuvant chemotherapy with paclitaxel plus platinum for invasive cervical cancer in pregnancy: two case report and literature review.
    Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cesarean Section; Cisplatin; Female; Humans; Live Birth; Neoadjuvant Therapy; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms

2011
[Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Paclitaxel; Precancerous Conditions; Radiotherapy, Adjuvant; Uterine Neoplasms

2007
Discussing disease progression and end-of-life decisions.
    Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Attitude to Death; Carcinoma in Situ; Cisplatin; Communication; Decision Making; Disease Progression; Euthanasia; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Physician-Patient Relations; Truth Disclosure

1999

Trials

3 trial(s) available for paclitaxel and Carcinoma, Intraepithelial

ArticleYear
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start.
    Urologic oncology, 2022, Volume: 40, Issue:1

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; BCG Vaccine; Carcinoma in Situ; Europe; Female; Humans; Hyaluronic Acid; Male; Middle Aged; Paclitaxel; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2022
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm, Residual; Paclitaxel; Prognosis; Reproducibility of Results; Survival Rate; Tumor Burden

2015
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study.
    The Journal of urology, 2011, Volume: 185, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Intravesical; Adolescent; Adult; Aged; Aged, 80 and over; BCG Vaccine; Biopsy, Needle; Carcinoma in Situ; Cystoscopy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Italy; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Selection; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Young Adult

2011

Other Studies

5 other study(ies) available for paclitaxel and Carcinoma, Intraepithelial

ArticleYear
Synchronous occurrence of hereditary gastric adenocarcinoma, gastrointestinal stromal tumor, and esophageal small cell and squamous carcinoma in situ: an extremely rare case report.
    BMC cancer, 2017, Nov-07, Volume: 17, Issue:1

    Topics: Carcinoma in Situ; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gastrectomy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Lymph Node Excision; Middle Aged; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Stomach Neoplasms; Treatment Outcome

2017
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors.
    Cancer letters, 2013, Sep-28, Volume: 338, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Insulin Receptor Substrate Proteins; MCF-7 Cells; Neoplasm Grading; Neoplasm Invasiveness; Paclitaxel; Phosphorylation; Signal Transduction; STAT6 Transcription Factor; Transfection

2013
Bevacizumab in the treatment of metastatic breast cancer: three case reports.
    Current opinion in oncology, 2011, Volume: 23 Suppl

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Capecitabine; Carcinoma in Situ; Carcinoma, Ductal; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A

2011
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
    Histopathology, 2007, Volume: 51, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma in Situ; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; Pancreatic Neoplasms; Tubulin

2007
[A case of synchronous bilateral double primary lung cancer successfully treated by Nd-YAG laser therapy and chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Humans; Laser Therapy; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Taxoids

1999